Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals-Reference-Cited by-同舟云学术

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals

Published:2022-08 Issue:3 Volume:23 Page:165-171
ISSN:1687-1979
Container-title:Arab Journal of Gastroenterology
language:en
Short-container-title:Arab Journal of Gastroenterology

Author:

Medhat Mohammed A.,El-Kassas Mohamed,Karam-Allah Haidi,Al Shafie Ahmed,Abd-Elsalam Sherief,Moustafa Ehab,Hassany Sahar M.,Salama Marwa,Abd Elghafar Mohamed S.,Sayed Hamdy,Badr Mohamed,Kamal Dalia T.,Shamseldeen Ahmed,Ossimi Ashima'a,Moaz Inas,Esmael Hossam El-deen,Ezz Eldin Azza M.,Ezzat Sameera,Abdelghaffar Hossam,Abdelghaffar Khaled

Publisher

Elsevier BV

Subject

Gastroenterology

Reference45 articles.

1. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks;Ashour;Pathogens,2020

2. Shi Y, Wang G, Cai X-p, Deng J-w, Zheng L, Zhu H-h, et al. An overview of COVID-19. J Zhejiang Univ Sci B 2020:1.

3. WHO. Global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments 2020.

4. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: a structured summary of a study protocol for a randomized controlled trial;Hosseini;Trials,2021

5. Coronavirus infections—more than just the common cold;Paules;JAMA,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel scaffolds identification against Mpro of SARS-CoV-2 using shape based screening and molecular simulation methods;Chemical Physics Impact;2024-06

2. PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY;INDIAN DRUGS;2024-02-28

3. Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review;Clinical Case Reports;2023-11

4. Rapid and validated UHPLC method for simultaneous determination of sofosbuvir, ledipasvir and paracetamol as commonly repurposed drugs for COVID-19 treatment: application in spiked human plasma;Future Journal of Pharmaceutical Sciences;2023-10-23

5. Computational insights into pediatric adenovirus inhibitors:in silicostrategies for drug repurposing;Journal of Biomolecular Structure and Dynamics;2023-08-29